Our Products
We are committed and passionate about helping patients having rare central nervous system and inflammatory disorders.
At Questcor our patients are our top priority. Through our research and development initiatives we strive to better understand rare and difficult-to-treat conditions, as well as how our products can play a role in treating such conditions. By doing so we hope to help our patients live healthier, stronger, and more productive lives.
For more information on our two marketed products please click the links below.
H.P. Acthar® Gel (repository corticotropin injection) is indicated for the treatment of acute exacerbations in patients with multiple sclerosis, and for several other uses.
Doral® (quazepam tablets, USP) is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.
For more information on the areas of research that we support please visit our Research Initiatives page.
